Browse by author
Lookup NU author(s): Abdullah Malik, Sanjay PandanaboyanaORCiD, Gourab Sen, Professor Stuart McPhersonORCiD, Dr Jess Dyson, Professor Derek Manas, Dr Steven MassonORCiD, John Hammond
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved. INTRODUCTION: Symptomatic umbilical hernias are a common cause of morbidity and mortality in patients with cirrhosis and end-stage liver disease (ESLD). This study set out to characterise the factors predicting outcome following repair of symptomatic umbilical hernias in ESLD at a single institution. METHODS: A retrospective review was performed of all patients with ESLD who underwent repair of a symptomatic umbilical hernia between 1998 and 2020. Overall survival was predicted using the Kaplan-Meier method. Logistic regression was used to determine predictors of decompensation and 30-day, 90-day and 1-year mortality. RESULTS: One-hundred-and-eight patients with ESLD underwent umbilical hernia repair (emergency n = 78, 72.2%). Transjugular shunting was performed in 29 patients (26.9%). Decompensation occurred in 44 patients (40.7%) and was predicted by emergency surgery (OR, 13.29; P = 0.001). Length of stay was shorter in elective patients compared to emergency patients (3-days vs. 7-days; P = 0.003). Thirty-day, 90-day and 1-year survival was 95.2, 93.2 and 85.4%, respectively. Model for ESLD score >15 predicted 90-day mortality (OR, 18.48; P = 0.030) and hyponatraemia predicted 1-year mortality (OR, 5.31; P = 0.047). Transjugular shunting predicted survival at 1 year (OR, 0.15; P = 0.038). CONCLUSIONS: Repair of symptomatic umbilical hernias in patients with ESLD can be undertaken with acceptable outcomes in a specialist centre, however, this remains a high-risk intervention. Patients undergoing emergency repair are more likely to decompensate postoperatively, develop wound-related problems and have a longer length of stay. Transjugular shunting may confer a benefit to survival, but further prospective trials are warranted.
Author(s): Malik AK, Varghese C, Pandanaboyana S, Sen G, Robinson S, McPherson S, Dyson J, Manas DM, Masson S, Hammond JS
Publication type: Article
Publication status: Published
Journal: European Journal of Gastroenterology & Hepatology
Year: 2022
Volume: 34
Issue: 10
Pages: 1060-1066
Online publication date: 01/10/2022
Acceptance date: 02/04/2018
ISSN (print): 0954-691X
ISSN (electronic): 1473-5687
Publisher: Wolters Kluwer Health, Inc.
URL: https://doi.org/10.1097/MEG.0000000000002417
DOI: 10.1097/MEG.0000000000002417
PubMed id: 36062496
Altmetrics provided by Altmetric
